Ligand validation:4ORK

GDP: GUANOSINE-5'-DIPHOSPHATE

GDP is a Ligand Of Interest in 4ORK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ORK_GDP_B_500	71%	42%	0.148	0.97	0.95	1.3	-	4	0	0	100%	1
4ORK_GDP_D_500	70%	41%	0.146	0.965	0.93	1.36	-	6	0	0	100%	1
4ORK_GDP_C_500	60%	45%	0.166	0.953	0.98	1.14	1	3	0	0	100%	1
4ORK_GDP_A_500	57%	41%	0.177	0.954	1.04	1.27	2	4	0	0	100%	1
5IQF_GDP_A_500	89%	34%	0.106	0.987	0.9	1.7	1	8	0	0	100%	1
5IQG_GDP_D_500	78%	49%	0.143	0.987	1.04	0.94	3	2	1	0	100%	1
1RRG_GDP_A_183	100%	17%	0.036	0.997	2.05	1.56	7	3	0	0	100%	1
2CXX_GDP_B_2401	100%	29%	0.031	0.989	1.26	1.57	1	3	0	0	100%	1
4LUC_GDP_A_204	100%	40%	0.036	0.992	1.22	1.11	2	2	0	0	100%	1
5YMX_GDP_A_301	100%	54%	0.038	0.994	0.92	0.85	1	-	2	0	100%	1
8V3A_GDP_B_201	100%	42%	0.036	0.991	1.1	1.14	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.